Weight Loss for Obese Prostate Cancer Patients on Androgen Deprivation Therapy

PURPOSE: Excess fat mass (FM) contributes to poor prostate cancer (PCa) prognosis and comorbidity. However, FM gain is a common side effect of androgen deprivation therapy (ADT). We examined the efficacy of a 12-wk weight loss intervention to reduce FM and maintain lean mass (LM) in ADT-treated obes...

Descripción completa

Detalles Bibliográficos
Autores principales: WILSON, REBEKAH L., NEWTON, ROBERT U., TAAFFE, DENNIS R., HART, NICOLAS H., LYONS-WALL, PHILIPPA, GALVÃO, DANIEL A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Clinical Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886363/
https://www.ncbi.nlm.nih.gov/pubmed/33009195
http://dx.doi.org/10.1249/MSS.0000000000002509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886363/
https://www.ncbi.nlm.nih.gov/pubmed/33009195
http://dx.doi.org/10.1249/MSS.0000000000002509

Ejemplares similares